HLA-C and neoplasm: Further, Capietto et al. and Yadav et al. demonstrated, using candidate neoantigens predicted from MC38, TRAMP-1, EMT6 and CT26 murine tumour lines, that non-anchor amino acid changes that increased p:MHC stability and therefore duration of TCR contact also increased immunogenicity [15,111].